REQUEST A DEMO
Total
USD $0.00
Search more companies

Grand Pharmaceutical Group Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Grand Pharmaceutical Group Limited Profile Updated: March 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Grand Pharmaceutical Group Limited, also known as 远大医药集团有限公司, is a technology-driven international pharmaceutical company based in Hong Kong. The company specializes in pharmaceutical technology, nuclear medicine for cancer treatment, precision intervention for cardiovascular and cerebrovascular diseases, and biotechnology. In 2002, Grand Pharmaceutical Group Limited underwent a change in its equity structure, leading to its indirect listing on the Hong Kong Stock Exchange. The company currently owns more than 30 subsidiary companies, which include divisions for respiratory and critical care anti-infection, oncology, cardiovascular emergency care, ophthalmology, precision intervention for cardiovascular and cerebrovascular diseases, nuclear medicine for cancer treatment, and high-quality amino acids.

Headquarters
Unit 3302, The Centre, 99 Queen'S Road, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Grand Pharmaceutical Group Limited report to view the information.

Basic Information
Total Employees:
Purchase the Grand Pharmaceutical Group Limited report to view the information.
Outstanding Shares:
Purchase the Grand Pharmaceutical Group Limited report to view the information.
Registered Capital:
Purchase the Grand Pharmaceutical Group Limited report to view the information.
Financial Auditors:
Purchase the Grand Pharmaceutical Group Limited report to view the information.
Incorporation Date:
October 18, 1995
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
56.3%
Purchase this report to view the information.
10.05%
Purchase this report to view the information.
8.06%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
East Ocean Medical
100%
Grand Decade Developments Limited (United Kingdom)
100%
Taiwan Tung Yang International Company Limited
100%
Company Performance
Financial values in the chart are available after Grand Pharmaceutical Group Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
14.9%
Total operating revenue
14.77%
Operating profit (EBIT)
23.52%
EBITDA
43.32%
Net Profit (Loss) for the Period
51.42%
Total assets
3.58%
Total equity
6.95%
Operating Profit Margin (ROS)
1.48%
Net Profit Margin
4.25%
Return on Equity (ROE)
2.13%
Debt to Equity Ratio
5.34%
Quick Ratio
-0.04%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?